Atypical femur fracture incidence in women increases with duration of bisphosphonate exposure | Zendy

Joan C. Lo | Zendy; Christopher D. Grimsrud | Zendy; Susan M. Ott | Zendy; Malini Chandra | Zendy; Rita L. Hui | Zendy; Bruce Ettinger | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Atypical femur fracture incidence in women increases with duration of bisphosphonate exposure

Author(s) -

Joan C. Lo,

Christopher D. Grimsrud,

Susan M. Ott,

Malini Chandra,

Rita L. Hui,

Bruce Ettinger

Publication year - 2019

Publication title -

osteoporosis international

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.28

H-Index - 170

eISSN - 1433-2965

pISSN - 0937-941X

DOI - 10.1007/s00198-019-05112-5

Subject(s) - medicine , bisphosphonate , incidence (geometry) , femur , orthopedic surgery , osteoporosis , population , femur fracture , complication , dentistry , surgery , environmental health , physics , optics

In a northern California population of older women who were treated with oral bisphosphonate drugs, the incidence of atypical femur fracture, a rare complication of treatment, increased with longer duration of bisphosphonate exposure. These findings align with those previously reported in an independent southern California population.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research